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Retinal detachment following cataract phacoemulsification - a review of the 
literature 
 
Abstract 
A link between cataract surgery and rhegmatogenous retinal detachment (RRD) has long been 
considered. Indeed, pseudophakic retinal detachment (PPRD) forms a substantial and 
increasing proportion of RRD. We reviewed the literature to answer the following questions: 
What is the incidence of PPRD in eyes following phacoemulsification cataract surgery and how 
does its risk change over time following surgery? We also sought to assess how the risk is 
modified by intraoperative factors (operative complications, surgeon grade, subsequent laser 
capsulotomy), intrinsic eye-related factors (laterality, myopia, previous RRD, previous trauma, 
previous PVD) and patient factors (sex, age, ethnicity, affluence, systemic comorbidities). 
Secondarily we asked how the incidence of PPRD after phacoemulsification compares to the 
RRD incidence in the general population and how identified risk factors contribute to the 
pathophysiology of PPRD.  
A search of the Medline and Ovid databases was conducted for relevant publications 
from 1990 onwards using defined search terms with pre planned inclusion and exclusion 
criteria.  
The 10-year PPRD incidence after phacoemulsification was identified as being between 
0.36-2.9%. This decreases over time to 0.1-0.2% annually but remains above the general 
population. The PPRD risk is further elevated by (in order of decreasing effect) intraoperative 
vitreous loss, increasing axial length, younger age, male sex and trainee operating surgeons. 
The PPRD risk after phacoemulsification is approximately ten times the general 
population’s RRD risk. This risk is modified by the interplay of a hierarchy of risk factors, of 
which intraoperative vitreous loss, myopia, age and sex have the biggest effect. 
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 3 
Introduction 4 
Rhegmatogenous retinal detachment (RRD) refers to the separation of the neurosensory retina 5 
from the underlying retinal pigment epithelium related to a break in the retina. RRD following 6 
cataract surgery (pseudophakic retinal detachment, or PPRD) forms a substantial and 7 
increasing proportion of RRD (1), with estimates varying from 21.6% (2) to 37.2% (3) of RRDs in 8 
the developed world being PPRDs. Cataract extraction is one of the most commonly performed 9 
surgical procedures globally with approximately 330,000 cataracts removed each year in 10 
England alone (4). This figure is likely to increase further with an ageing population. It is 11 
important to understand the relationship between cataract extraction and PPRD as it is a 12 
serious, vision-threatening event with approximately half of all patients not recovering better 13 
than driving vision (visual acuity 6/12) (5). 14 
 15 
The risk of PPRD varies with the method of cataract extraction. Conventional extracapsular 16 
cataract extraction (ECCE) carries a lower risk of PPRD by approximately one third compared to 17 
its predecessor, intracapsular cataract extraction (ICCE) (6). ECCE has in turn been replaced 18 
almost entirely by phacoemulsification in the developed world, starting in the early 1990s (7, 8). 19 
The early literature on phacoemulsification suggested an intermediate  PPRD risk, between that 20 
of ICCE and ECCE (6). However, these estimates may not reflect the true PPRD risk given 21 
refinements and greater familiarity and training in phacoemulsification since its early 22 
popularisation. This seems to be borne out by long-term studies reporting declining overall 23 
PPRD rates (9) and more recent studies finding equivalent (10) or lower (11) rates of PPRD 24 
after phacoemulsification as compared to ECCE. 25 
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 26 
The risk of PPRD after phacoemulsification is estimated variously at between 0.036% (12) to 27 
0.656% (13) at 12 months. In comparison the incidence of primary RRD in the general 28 
population is between 0.0104% (14) to 0.0207% (3), implying that phacoemulsification 29 
increases risk of RRD by at least a factor of 1.7. This risk of PPRD is proposed to be further 30 
altered by a variety of demographic and intraoperative factors including age, sex, myopia and 31 
intraoperative complications etc. 32 
 33 
Quantifying the risk of PPRD and the effect of these additional risk factors is important for 34 
clinicians and patients to make an informed decision before proceeding with cataract extraction. 35 
Previous reviews of the literature cannot directly answer this question as they date back to 36 
before the near-universal spread of phacoemulsification as the main surgical technique or make 37 
no distinction between phacoemulsification and other techniques (including refractive lens 38 
exchange which may confound results due to a predominantly young, myopic population with 39 
consequently higher native RRD risk). 40 
 41 
In this review we attempt to draw together the findings of studies available from 1990 onwards 42 
examining the effect of phacoemulsification cataract surgery on the risk of retinal detachment 43 
and additional factors that modify this risk. 44 
 45 
Baseline Risk of RRD in the general population 46 
The incidence of RRD in the general population is between 0.01-0.02% and is associated with 47 
greater socioeconomic prosperity and male sex (men are at approximately double risk). Right 48 
eyes are affected more often than left and the peak incidence of RRD is around the sixth 49 
decade of life (15).  RRD risk varies with ethnicity; Caucasians are estimated to be at ten-fold 50 
higher risk than African populations (16). Asian populations have younger age of onset (17, 18)  51 
3 
 
but incidence varies; East Asians are at similar risk to Caucasians (14) whereas South Asians 52 
have lower risk of RRD, estimated to be threefold less than Caucasians (19, 20). Myopia, fellow 53 
eye RRD and proliferative diabetic retinopathy, myopia and fellow eye RRD are significantly 54 
associated with higher RRD risk (21, 22). Nd:YAG laser capsulotomy has previously been 55 
considered a risk factor for RRD - this has more recently been challenged (23).  56 
 57 
In 80-90% of RRDs the precipitating event is a retinal break associated with a posterior vitreous 58 
detachment (PVD) (24). PVD is a natural, age-related result of progressive vitreous liquefaction 59 
and increases rapidly around age 60-70 years. It has been estimated that, in between 8-15% of 60 
people affected, this is associated with retinal break formation (25, 26). It has also been 61 
suggested that established and complete PVD without RRD at presentation is protective against 62 
RRD when cataract surgery is performed (22, 27). 63 
 64 
Methodology and Search Strategy 65 
We conducted a search of the Medline and Ovid databases for all publications from 1990 using 66 
the search terms: 67 
 68 
(retinal detachment) AND (pseudophak* OR phacoemulsification OR (Cataract AND (surgery 69 
OR operation OR extraction OR removal))) 70 
 71 
This yielded 2634 results which were supplemented by manual searches primarily using 72 
additional references from key articles. Inclusion criteria included: prospective or retrospective 73 
studies of RRD incidence in a predominantly post-phacoemulsification population and English 74 
language. Papers which met our criteria were analysed for PPRD incidence overall and by risk 75 
factor. Any papers whose eligibility was not clear from the abstract were retrieved and read to 76 
ascertain whether they merited inclusion. Exclusion criteria were: population size of <1000 77 
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pseudophakic eyes, inclusion of phacoemulsification performed pre-1990, inclusion of refractive 78 
(clear) lens exchange phacoemulsification, populations with >40% ICCE or ECCE, solely 79 
paediatric population and incomplete data.  80 
 81 
A summary of the findings of the 16 papers that met these criteria is provided in Table 1 and 82 
discussed below. In summary, the population sizes ranged from 1793 to 2,680,167 with an 83 
estimated total of 3,211,671 pseudophakic eyes. Four papers were by the same Taiwanese 84 
group (Sheu and colleagues) following a fixed population over multiple years of follow up (10, 85 
28-30). In addition to these four, a fifth study by a different group was also based in Taiwan (31), 86 
a sixth in Singapore (32) and a seventh in New Zealand (33). All other studies investigated 87 
phacoemulsification in European centres. Minimum study follow up durations from the time of 88 
cataract surgery ranged from no defined minimum duration (11, 31) (i.e. PPRD incidence 89 
calculated over the same time periods as phacoemulsification) to 10 years post-90 
phacoemulsification (33). Three studies retrospectively calculated the frequency of individual 91 
risk factors present in PPRD eyes compared with the frequency in unaffected pseudophakic 92 
eyes (32, 34, 35). All other studies stratified the pseudophakic population by presence or 93 
absence of risk factors and prospectively calculated the incidence of PPRD. 94 
 95 
Overall incidence in pseudophakic population 96 
The reported incidence of PPRD varied considerably between studies and also with the length 97 
of follow up. The lowest reported cumulative incidence of PPRD was 0.36% over 10 years (12), 98 
equating to an annual incidence of 0.036% (by Szijártó and colleagues in Hungary) while Sheu 99 
et al. reported 2.31% over 8 years in their final published follow up (10), equating to 0.289% per 100 
annum which is the highest value in our review. In general however, studies with longer follow 101 
up report a greater cumulative incidence of PPRD with an approximately linear relationship 102 
corresponding to an incidence of 0.1-0.2% for each addition year after phacoemulsification (see 103 
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Figure 1). This is supported by evidence that the risk of RRD in pseudophakic eyes remains 104 
significantly elevated for over a decade after the operation (36). 105 
 106 
PPRD risk over time following phacoemulsification 107 
Nine studies investigated how the PPRD incidence evolves with time from phacoemulsification. 108 
Three  found no period of increased incidence (11, 33, 37) while one found a late increase in 109 
incidence after 4 years for myopic males only (10). A further three reported a higher PPRD 110 
incidence in the first 6-24 months post-phacoemulsification (28, 34, 38). An eighth study found a 111 
significantly shorter median time from phacoemulsification to PPRD (44 days compared to 6.3 112 
months) if the eye suffered intraoperative posterior capsule rupture (PCR) or if the operator was 113 
a trainee surgeon independently of whether PCR occurred (figures not given) (39). 114 
Notwithstanding the short follow up in this study (minimum three months) the implication is that 115 
the early postoperative period carries higher risk of PPRD. Moreover this finding is corroborated 116 
by a ninth study which found the first year after phacoemulsification to have the greatest risk of 117 
PPRD and that the median time to PPRD was shortened from 31 months to 10 months in eyes 118 
which suffered PCR with vitreous loss (12).  119 
 120 
The five studies reporting increased PRPD risk in the early postoperative period do not 121 
necessarily negate an additional long-term increase in PPRD risk. Indeed Bjerrum and 122 
colleagues note that the while the highest PPRD risk is during the first six months (Hazard 123 
Ratio, HR of 9 relative to the un-operated fellow eye) and then decreases, the PPRD risk 124 
plateaus at two years (HR 3) and remains higher than the fellow eye for a decade (38). 125 
 126 
While the case for an early increased PPRD risk is compelling given the link with intraoperative 127 
complications, it may also in part reflect greater surveillance in the early postoperative period, 128 
especially in complicated cases, and increasing patients lost to follow up with time. 129 
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 130 
PPRD risk after phacoemulsification in comparison to ECCE 131 
As earlier estimates may have overestimated the PPRD risk after phacoemulsification due to 132 
the technique’s unfamiliarity, we selected studies in which phacoemulsification was the 133 
predominant cataract extraction method. Nevertheless, six studies which included some ECCE 134 
cases compared the PPRD incidence in ECCE and phacoemulsification cases.  135 
 136 
Daien et al. found a higher PPRD incidence after ECCE cases (HR 3.11) (11). All other studies 137 
reported no significant difference (28-31) with the exception of Sheu et al. who in their final 138 
follow up found phacoemulsification was associated with a higher PPRD incidence (Relative 139 
Risk, RR of 1.78). Interestingly in their previous follow up papers (2005-2007) this difference did 140 
not reach significance in the overall population. Moreover, they note that in their final study that 141 
the increased risk after phacoemulsification was attributable to cases from the first year of their 142 
operative period (c.1999). This period corresponded to a changeover from ECCE to 143 
phacoemulsification and the two techniques had no significant difference in PPRD incidence 144 
when only considering cases from the following year (10).  145 
 146 
Unifying the results of these studies it would appear that phacoemulsification is as safe or safer 147 
than ECCE once the technique is familiar. For centres transitioning from ECCE to 148 
phacoemulsification, the newer technique may well have a greater PPRD risk and previous 149 
studies which found a higher PPRD risk after phacoemulsification than ECCE should be viewed 150 
as overestimates in light of this. Conversely, we note (as did Daien and colleagues), that current 151 
estimates of higher PPRD risk after ECCE than phacoemulsification may be confounded by the 152 
fact that in centres where phacoemulsification is the dominant technique, ECCE is now reserved 153 
for more challenging cases such as cataracts with denser crystalline lenses not amenable to 154 
phacoemulsification. 155 
7 
 
 156 
Intraoperative complications 157 
All groups who examined the effect of intraoperative complications (vitreous loss or PCR), found 158 
a significant association with increased PPRD except Sheu et al. and Boberg-Ans and 159 
colleagues in their first study (34). The estimated increase in risk varied from approximately 160 
fourfold at four years (11) to as high as 42 times higher risk of retinal detachment surgery within 161 
3 months following PCR (4). The latter figure is from Day et al. who found this higher initial 162 
PPRD risk following PCR decreased over time (OR 23.98 and 18.28 at 6 and 12 months 163 
respectively). As previously mentioned, the same group also found in a different study that PCR 164 
was associated with a shorter time to PPRD (39). 165 
 166 
In the only other study to examine the effect of intraoperative complications on the time from 167 
phacoemulsification to PPRD, Szijártó et al. likewise found PCR associated with shorter time to 168 
PPRD but only if accompanied by vitreous loss (12). This point is also borne out by the 169 
observation that among the nine studies which found higher incidence of PPRD in eyes 170 
suffering intraoperative complications, five considered intraoperative complications collectively 171 
(i.e. without distinguishing the presence or absence of vitreous loss) (4, 12, 31, 32, 39) while 172 
four specified PCR with vitreous loss as being associated with higher PPRD risk (11, 33, 35, 173 
40). Of these, Russell et al. and Petousis et al. specifically compared the PPRD risk in eyes 174 
suffering PCR with and without vitreous loss and found increased PPRD only in cases of PCR 175 
with vitreous loss, with no significant increase in PPRD risk in eyes suffering PCR without 176 
vitreous loss. The implication of this would be that intraoperative complications per se are not 177 
associated with higher PPRD risk, rather vitreous loss is. This may be to do with the 178 
pathophysiology of PPRD, as explored below, but has significance in terms of detection, 179 
management and training of PCR intraoperatively. 180 
 181 
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Surgeon grade 182 
One study meeting our inclusion criteria examined the effect of surgeon grade on PPRD by 183 
classifying operators into trainee, independent non-consultant and consultant surgeons. They 184 
found a shorter time from phacoemulsification to RRD in eyes operated on by more junior 185 
surgeons (39). The authors did not comment on whether the overall rate was higher after 186 
cataract extraction by junior surgeons but in light of this finding this is likely to be the case at 187 
least in the immediate post-operative period. Given the short follow up time of this study it is 188 
unclear whether this only reflects a higher early incidence and whether over longer post-189 
operative follow up the PPRD incidence is significantly different if operated on by consultants. 190 
 191 
Intraoperative complications are more likely at the hands of a trainee surgeon (4) and surgeon 192 
grade is a variable in the current PCR risk calculator (41). However, this study finds the lower 193 
surgeon grade increases PPRD risk independently of PCR. If this is the case it could be 194 
hypothesised that the increased risk also relates to greater anterior chamber fluctuations, more 195 
prolonged surgery and infusion volumes into the eye. 196 
 197 
More generally, familiarity of surgical teams with phacoemulsification decreases PPRD risk as 198 
demonstrated by Sheu and colleagues who showed that a transition from ECCE to 199 
phacoemulsification was marked by initially higher PPRD incidence following 200 
phacoemulsification. This became non-significant one year after transition away from ECCE as 201 
the predominant cataract extraction technique (10). 202 
 203 
Nd:YAG capsulotomy 204 
Nd:YAG capsulotomy has previously been associated with increased post-cataract extraction 205 
RRD risk (42, 43) but all seven studies meeting our criteria found no significant link with 206 
increased PPRD overall in their post-phacoemulsification population. However in a sub-group 207 
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analysis, Lin et al. found that high myopes had an increased PPRD risk if they underwent 208 
Nd:YAG capsulotomy (31). Similarly Sheu et al. in their first follow up found an association in 209 
their sub-group of patients aged under 50 years but none in their overall pseudophakic 210 
population (28). Unfortunately, although Sheu and colleagues’ subsequent follow up studies 211 
confirmed that capsulotomy is not significant overall, they did not revisit whether this remained 212 
significant in younger eyes over a longer period of follow up. 213 
 214 
Unlike studies focusing only on post-capsulotomy PPRD risk (none of which met our inclusion 215 
criteria), the studies in our review were all primarily concerned with post-phacoemulsification 216 
risk with Nd:YAG capsulotomy considered secondarily. Because of this, their results may be 217 
confounded by follow-up times that were calculated from phacoemulsification rather than from 218 
capsulotomy. None of the included studies gave data on time lags between phacoemulsification 219 
and capsulotomy, introducing an uncontrolled variable. Moreover, given that this may have 220 
occurred as much as 2 years after phacoemulsification this shortens the time during which post-221 
capsulotomy PPRDs can occur and would be expected to underestimate the effect of laser 222 
capsulotomy when incidence is calculated from the time of phacoemulsification.  223 
 224 
This uncertain significance of laser capsulotomy on PPRD risk in our selected studies is in 225 
keeping with more recent studies (44), including a review of the literature which suggests that 226 
there is no convincing association between Nd:YAG capsulotomy and PPRD (23), though, like 227 
Lin et al., the authors note that a significant association may exist for myopic eyes undergoing 228 
capsulotomy.   229 
 230 
These observations may be reconciled with findings to the contrary, especially by older studies, 231 
in light of a study by Olsen and Olson which considered 1099 ECCE and 1418 232 
phacoemulsification cases, with approximately one third of each group going on to have laser 233 
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capsulotomy. They found that whilst Nd:YAG capsulotomy was significantly associated with 234 
PPRD after ECCE, it had little impact on PPRD risk in the context of phacoemulsification (45), 235 
perhaps relating to consistent intracapsular IOL fixation and more assured ‘separation’ of the 236 
anterior and posterior segments. 237 
 238 
Axial length and Myopia 239 
As with phakic RRD, myopia was strongly associated with increased PPRD risk in all 11 studies 240 
that considered it. All studies used axial length rather than refractive error and the definition of 241 
myopia varied between the various groups from >23 mm to >25 mm. Estimates varied between 242 
a 2.74 (40) to 18.90 (31) times increased risk compared to non-myopes. Sheu and colleagues 243 
found female sex (30) and older age (28) were protective against the increased PPRD risk from 244 
myopia. 245 
 246 
Six studies grouped their patients by axial length and demonstrated a dose-dependent 247 
relationship between axial length and PPRD risk. Lin et al, who found the most pronounced 248 
effect, found eyes with axial length 23-26 mm had a non-significant adjusted relative risk of 3.92 249 
compared to eyes with axial length <23mm while eyes with axial length >26 mm had a 250 
significantly increased relative risk of 18.90. (31). Importantly they also found a significant, dose-251 
dependent protective effect of being non-myopic against the effects of young age and 252 
intraoperative complications (see Table 2). 253 
 254 
Previous RRD in operated eye 255 
Previous RRD is a strong risk factor for phakic re-detachment in the same eye. On this basis it 256 
might be expected that after phacoemulsification such eyes would likewise show a higher PPRD 257 
incidence. Forsell and colleagues recently demonstrated a low rate of PPRD in a small group of 258 
patients with previous RRD in the operated eye (46). Unfortunately, this study did not meet our 259 
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criteria and the majority of those that did excluded eyes with previous RRD. The only study in 260 
our review to investigate the effect of previous RRD on PPRD risk in the same eye found no 261 
significant difference, unsurprisingly given the small numbers concerned (2 PPRDs in a 262 
population of 11 eyes with RRD preceding phacoemulsification) (33). 263 
 264 
 265 
Previous RRD in fellow eye 266 
A previous RRD in the fellow eye is known to be a strong risk factor for phakic RRD in the 267 
contralateral eye. However only two studies examined the significance of fellow eye RRD on 268 
PPRD on the contralateral side. Russell et al. found a minimally significant increased risk if the 269 
fellow eye had suffered a RRD (33), while Sheu et al. found such eyes at much higher risk of 270 
PPRD risk (crude RR 17.34) (10). The latter study had a much larger population size (9388 271 
pseudophakic eyes in Sheu et al. compared to 1793 in Russell et al.) though the number of 272 
operated eyes with a history of fellow eye RRD is small in both (6 in Sheu et al. and 4 in Russell 273 
et al.) and is more likely to account for the large difference in findings. We would also expect 274 
that the nature of the fellow eye RRD may alter the risk of PPRD differently depending on how 275 
long ago it occurred and whether the detachment was a primary rhegmatogenous RRD or 276 
secondary to trauma or an intraocular tumour.  The dearth of available data addressing this is 277 
likely due to the comparatively small number of eyes in this category making further subdivision 278 
of fellow eye RRD unfeasible. 279 
 280 
Ocular trauma 281 
Ocular trauma is a known risk factor for RRD. The incidence of RRD following trauma is 282 
estimated at around 5% over 6 months (47). In our review of PPRD risk factors, many studies 283 
excluded eyes with a history of trauma. Of the ten that did not, only three examined the effect on 284 
PPRD incidence. In two retrospective studies, Boberg-Ans et al. and Olsen et al. found that 285 
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eyes that had suffered PPRD had no significantly higher chance of having had a history of 286 
ocular trauma (34, 35).  Both studies were comparatively small, especially when considering 287 
their sub-population of eyes which had previously suffered trauma (Boberg-Ans et al. found 1 288 
eye with previous trauma out of 22 PPRDs in a total population of 6521 pseudophakic eyes and 289 
Olsen et al. found 7 eyes with previous trauma out of 48 PPRDs in a total population of 12,222 290 
pseudophakic eyes).  291 
 292 
In contrast, in a much larger study (203 eyes with previous trauma out of 11,424 PPRDs in a 293 
total population of 2,680,167 pseudophakic eyes) Daien et al. found eyes with a history of 294 
trauma were at significantly increased PPRD risk (HR 3.98) (11). This finding is more in keeping 295 
with the known increased RRD risk in the general population after ocular trauma and so the 296 
findings of the earlier two studies may be the result of smaller population sizes. 297 
 298 
It is also conceivable that the risk of PPRD in such eyes varies with the nature and severity of 299 
the trauma, how long ago it occurred, whether it disrupted the vitreous or retina and what, if any, 300 
treatment was given. Given these additional factors, ocular trauma per se may not be as helpful 301 
a variable in calculating PPRD risk as defined injuries to specific anatomical structures. 302 
Realistically however it may be difficult to recruit populations of sufficient size to be able to 303 
further subdivide eyes in such a way. 304 
 305 
Gender 306 
In the general population, RRD is more common in men than women, with the sex ratio 307 
estimated at between 1.5:1 (48) and 2:1 (1). Of the 14 studies investigating the effect of sex on 308 
PPRD risk after phacoemulsification, 10 found a significantly greater incidence of PPRD in men, 309 
with the increased risk between 1.72 (10) to 3.39 (33) times that of women. Of the remaining 310 
four, two are the 2005 and 2006 studies by Sheu et al. who went on to demonstrate in their 311 
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subsequent studies of the same population that with increasing follow up men did have a higher 312 
PPRD risk than women (10, 30). 313 
 314 
This raises the question of whether the increased PPRD incidence in men is genuinely 315 
attributable to phacoemulsification or whether over such long follow up the increased incidence 316 
reflects the higher background RRD risk for men. Exploring this, Bjerrum and colleagues 317 
compared PPRD incidence in the operated eye to RRD in the un-operated fellow eye, finding 318 
that, when adjusted for the higher PPRD incidence in male un-operated fellow eyes, the 319 
attributable increase in PRPD risk of male operated eyes was not significantly more than 320 
women, i.e. phacoemulsification increases the risk of RRD uniformly irrespective of sex and the 321 
higher incidence of PPRD in males is due to a higher pre-operative risk (38). 322 
 323 
If this is true, men are still at greater risk of PPRD than women following phacoemulsification but 324 
to understand why this is the case pre-operative risk factors for RRD are more significant. Olsen 325 
and colleagues suggest the answer lies in male eyes being longer than female eyes (i.e. a 326 
higher incidence of myopia in men) which is a known risk factor for RRD (35). While this is true 327 
of the Danish population studied by Olsen et al. (49) and has been invoked to explain the male 328 
preponderance of RRD in a Scottish population (50), the global picture is more unclear. While 329 
women show higher incidence of hyperopia (Odds ratio, OR 1.28), myopia shows similar 330 
prevalence in men and women globally when adjusted for age and race. Moreover in some 331 
populations women have significantly higher rates of high myopia than men, (e.g. OR 1.61 in 332 
white Australians) (51). It has also been suggested that posterior migration of the posterior 333 
border of the vitreous base contributes to the higher incidence of RRD in men (50, 52). 334 
 335 
Furthermore, the higher PPRD risk in men seems to be independent of the effect of age, axial 336 
length and previous ocular trauma. In a population excluding eyes with a history of trauma, 337 
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Sheu and colleagues found female sex mitigates the additional risk from young age and myopia, 338 
strengthening the case for a different explanation which they suggest may be a greater 339 
incidence of unreported ocular trauma in males than females (30). 340 
 341 
Age 342 
All papers examining age as a risk factor found young age significantly associated with PPRD, 343 
contrary to the wider population’s increased risk or RRD with age up to around 60. Those 344 
studies which grouped their study population into age brackets all found a dose-dependent 345 
relationship between increasing age and lower PPRD risk. The most modest increase is 346 
reported by Sheu et al. who, in their final follow up study, found a relative risk of 2.69 for 347 
patients aged under 50 compared to those aged over 60 years (10). The largest age-dependent 348 
risk modification is reported by Petousis et al. who found those aged under 60 at approximately 349 
40-fold greater risk of PPRD than those aged over 80 years (40). This lower PPRD risk in older 350 
patients appears to be independent of sex and also mitigates the additional PPRD risk in 351 
myopic eyes (28). 352 
 353 
Bjerrum et al. note that above the age of 50 PPRD risk drops exponentially by just over half for 354 
each decade (38), a relationship which also approximates to the results of several other studies 355 
in this review, although due to differences in age bracketing this is difficult to quantify. This 356 
observation is also in line with an older estimate of change in PPRD risk following ECCE by a 357 
Swedish group who found PPRD risk changed by a factor of 0.94 for each additional year of 358 
age, which when raised to the tenth power corresponds to a factor of 0.54 over a decade (53).  359 
 360 
However, Bjerrum and colleagues found this increased risk also applied to RRD in fellow un-361 
operated eyes, i.e. phacoemulsification increases the risk of RRD uniformly irrespective of age. 362 
This would suggest that higher incidence of PPRD in younger patients is due to a higher pre-363 
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operative risk (38). Given younger eyes in the general population have a lower native RRD risk, 364 
the higher risk in these patients may presumably be attributed to pathological processes which 365 
predispose both to early cataracts and easily detached retinas. 366 
 367 
Systemic diseases 368 
Of the studies considering the impact of systemic diseases (primarily hypertension and 369 
diabetes), all found no significant effect (10, 29-31) other than Daien and colleagues who found 370 
an increased PPRD risk in diabetics (HR 1.18) (11). If so, this may be the result of traction on 371 
the retina from proliferative diabetic retinopathy which is a known risk factor for RRD in the 372 
general population and was implicated in a British study which found a rise in RRD attributable 373 
to an increased prevalence of diabetes (54). 374 
 375 
Ethnicity 376 
Comparisons of RRD incidence in the general population have found differences depending on 377 
ethnicity with Caucasian, Asian and African populations associated respectively with higher, 378 
intermediate and lower RRD risk. Quek et al’s study of a Singaporean population is the only one 379 
in our review to examine the risk of PPRD as affected by ethnicity, finding no significant effect 380 
(32). This study is limited by its short follow up duration (minimum 6 months) and consequently 381 
low number of PPRDs (total 39) making underestimation of risk more likely. The authors also 382 
did not specify which ethnicities they compared in their population. This is especially important 383 
as the literature on the effect of race on phakic RRD incidence suggests a tendency among 384 
East Asian authors to compare within Asian sub-populations (Chinese, Indian, Malay etc.) 385 
whereas Western authors tend to compare more broadly between Caucasian, Asian or African 386 
populations. This methodological difference may significantly alter whether or not a particular 387 
study finds differences in RRD or PPRD incidence  388 
 389 
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Other risk factors 390 
In the general population right eyes are at greater risk of RRD than left eyes. No studies that 391 
met our criteria examined the effect of laterality on PPRD risk, although it has been postulated 392 
in phakic eyes that it may be related to ocular dominance and myopia. Likewise, while some 393 
studies have linked affluence with increased RRD risk, there is currently no literature 394 
investigating this as a risk factor for PPRD specifically. Similarly, although PVD is known to be 395 
associated with RRD, we found no studies meeting our criteria which considered the effect of 396 
PVD on PPRD incidence. 397 
 398 
Phacoemulsification-attributable risk 399 
Bjerrum and colleagues highlighted a largely neglected consideration which is that the 400 
increased rate of RRD in the pseudophakic population is not necessarily attributable to cataract 401 
extraction. Cataract-prone eyes may have an increased native risk of RRD and a small study of 402 
64 patients has previously demonstrated increased risk of RRD in the un-operated fellow eyes 403 
of PPRD patients (55). As such the most appropriate control, rather than being the general 404 
population, is the fellow eyes of the same patients. With this in mind they still find a significant 405 
attributable risk to phacoemulsification (1.36 PPRDs per 1000 person-years in the operated eye 406 
compared to 0.32 in the fellow eye). Interestingly however, while they found young age and 407 
male sex significantly associated with PPRD, this became insignificant when compared to the 408 
comparably increased fellow eye RRD risk in these patients. The implication of this would be 409 
that while young males with cataracts are at higher risk of RRD, the phacoemulsification 410 
procedure increases the risk uniformly (by a factor of 4.2 in this study) irrespective of age or 411 
sex. 412 
 413 
As this study remains the only one to present data on fellow eye RRD incidence and only 414 
investigated age and sex, we are unable to comment definitively on how this would modify the 415 
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attributable risk of PPRD as calculated by other groups and how this would vary with other risk 416 
factors, but we would expect it to be lower than previous calculations comparing to the wider, 417 
cataract-free population. Nevertheless, even with this analysis, the additional PPRD risk 418 
following phacoemulsification will precipitate more PPRDs in populations whose native RRD risk 419 
is high. 420 
 421 
This methodological approach is hampered however by the typically short duration between 422 
phacoemulsification of one eye and its fellow. Furthermore, if a cataractous eye has a higher 423 
native risk of RRD, the fellow eye may have a reduced native RRD risk if it does not develop a 424 
cataract till later in life making it no better a control than the general population – Bjerrum and 425 
colleagues note however that their study period was marked by many patients who developed 426 
cataracts simultaneously but had long waiting times between cataract extractions which may 427 
mitigate this to some degree. Perhaps most conspicuously, this study excluded eyes that 428 
suffered intraoperative complications, a risk factor unambiguously related to the 429 
phacoemulsification procedure and not shared with the fellow eye.  430 
 431 
Finally, this approach underemphasises the potential effect of a small additional risk on eyes 432 
with an already high baseline RRD risk. From a patient perspective, overall PPRD risk is the key 433 
concern – even if the proportion of this risk attributable to phacoemulsification is small, this is 434 
more likely to precipitate RRD in populations at higher baseline risk. 435 
 436 
Pathophysiology of PPRD 437 
In an effort to establish a causative link between cataract extraction and PPRD, Mahroo and 438 
colleagues analysed the clinical features of phakic RRDs and PPRDs in 500 eyes and found 439 
differing patterns in position and size of breaks between the two groups (56). In comparison to 440 
phakic RRDs, PPRDs presented less frequently with vitreous haemorrhage and more frequently 441 
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with multiple breaks, breaks smaller than 0.5-disc diameter and with breaks in the inferonasal 442 
quadrant and at the more surgically challenging 5 o’clock to 7 o’clock position. To further dissect 443 
whether the difference in pathophysiology of phakic RRDs and PPRDS is purely due to 444 
phacoemulsification or the cataractous eye itself, the authors further compared between phakic 445 
eyes with cataract and pseudophakic eyes, finding a similar pattern of differing clinical features 446 
between the RRDs of both groups as they did between pseudophakic eyes compared to all 447 
phakic eyes. If replicable, this study’s results would strongly support the phacoemulsification 448 
procedure as contributing a distinct additional risk. 449 
 450 
It has been suggested that the mechanism of PPRD involves vitreous changes during and after 451 
phacoemulsification (57). This draws on the fact that RRD in phakic eyes is typically preceded 452 
by PVD (24) although only a small proportion of PVDs are associated with RRD. The age-453 
related liquefaction of the vitreous that naturally results in PVD progresses most rapidly in the 454 
sixth decade of life, explaining the peak incidence of RRD. The increased RRD risk with PVD is 455 
in the acute setting, after which established (chronic) PVD is believed to be protective against 456 
subsequent RRD (22, 27). 457 
 458 
A similar process may occur as a result of acute vitreous traction caused by movement of the 459 
lens capsule during phacoemulsification. This would also explain why PCR and specifically 460 
vitreous loss so dramatically increases the risk of PPRD in the studies we reviewed, and why 461 
this increased risk seems to become less marked over time. This mechanism would also explain 462 
the higher incidence of PPRD after ICCE. 463 
 464 
Changes in vitreous tractional forces may also underpin the longterm increased rate of PPRD 465 
beyond the early postoperative period. The protuberance of the posterior surface of the native 466 
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lens is thought to reduce vitreous traction on the peripheral retina (58). This protective effect 467 
may be reduced in pseudophakia and lost in aphakia. 468 
 469 
Changes in the composition of the vitreous may also be implicated. A post-mortem study of 470 
three pseudophakic and seven phakic eyes found changes in the protein composition and 471 
structure of the vitreous humour after phacoemulsification that were not present in the phakic 472 
eyes which included two un-operated fellow eyes. The authors noted in particular the presence 473 
of crystallins (which are absent in phakic eyes) in the anterior vitreous and lower viscosity in the 474 
anterior than the posterior vitreous (which represents a reversal of the viscosity gradient in 475 
phakic eyes). The authors conclude that the vitreous’ normal protein processing and clearance 476 
mechanisms are altered in pseudophakic eyes (59). These alterations may destabilise the 477 
vitreous body and by disrupting the native clearance mechanisms may go on to cause further 478 
changes which underpin the long-term increase in PPRD risk, perhaps by accelerating the 479 
process of liquefaction and syneresis that results in PVD. 480 
 481 
Finally, this model is further supported by studies suggesting a high incidence of PVD after 482 
phacoemulsification. A small study of 49 eyes by Ivastinovic and colleagues found 59.2% had 483 
new PVD at 1 month after phacoemulsification and 71.4% at 3 months (60). A larger study of 484 
188 eyes found 78.7% of eyes without pre-existing PVD developed one by 26 months after 485 
phacoemulsification. Interestingly, the incidence was higher (87.23%) if the eye had pre-486 
operative lattice degeneration (retinal thinning with separation and liquefaction of overlying 487 
vitreous) (61). 488 
 489 
We note that Daien et al. have built on this model to suggest an explanation for the higher 490 
PPRD risk in younger eyes (in contrast to the lower phakic RRD risk in younger eyes, making 491 
age the only risk factor whose effect differs in phakic RRD and PPRD). They suggest that older 492 
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eyes are more likely to have an established pre-operative PVD which is therefore protective 493 
against vitreous changes during and after phacoemulsification (11). However, in light of Bjerrum 494 
and colleagues’ work using the un-operated fellow eye as a control, we would expect this to be 495 
reflected in a higher PPRD risk in younger eyes directly attributable to the procedure. In reality 496 
Bjerrum at al. found no significant difference due to age on the risk directly attributable to the 497 
procedure, instead finding the higher risk in younger eyes was entirely attributable to a higher 498 
pre-operative risk in young patients (calculated using fellow eye incidence) (38). In fact 499 
Ivastinovic et al. found a higher incidence of new PVD after phacoemulsification in those aged 500 
over 70 (92.3% compared to 47.8%) (60), all of which suggests that the lower PPRD incidence 501 
in older eyes is not entirely due to the protective effect of a pre-existing PVD. 502 
 503 
Limitations 504 
The available literature is also limited by small population sizes. Due to the relative rarity of 505 
PPRD, even with our criteria including population >1000 the number of PPRDs occurring is low; 506 
only 4 of our 16 studies had more than 50 PPRDs. The available literature also frequently 507 
excluded eyes with previous RRD and some had very short follow up durations (4). In some 508 
studies PPRD incidence was calculated over a fixed data collection period without adjusting for 509 
the fact that the patients underwent phacoemulsification during the same time window (11, 31, 510 
32, 39) which may lead to underestimation of the crude PPRD rate. Conversely studies with 511 
long follow up times may overestimate the risk of PPRD attributable to phacoemulsification in 512 
younger patients due to the natural history of RRD – without adjusting for age, over long follow-513 
up durations younger patients are more likely than older patients to have a RRD in later life 514 
which is wrongly attributed to phacoemulsification even if the durations of follow up are equal. 515 
This may explain why Szijarto and colleagues found that while younger patients had a higher 516 
estimated PPRD incidence, the mean time between phacoemulsification and PPRD was longer 517 
(12). 518 
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 519 
More broadly our survey of the literature was limited by methodological differences between the 520 
different studies considered, particularly in how they quantified risk factors for PPRD, making 521 
direct comparisons more challenging. The populations of some studies are also wholly or partly 522 
subsumed in others (e.g. Olsen et al. examined phacoemulsification patients at a single Danish 523 
centre from 2000 to 2005 (35) all of whom should also be included in the Danish National 524 
Patient Registry which was used by Bjerrum et al. to examine all Danish patients from 2000 to 525 
2010 (38)).  526 
 527 
Conclusions 528 
In our survey of the recent literature, PPRD remains a rare but important adverse outcome 529 
occurring in 0.36-2.9% of cases within 10 years of phacoemulsification. In line with more recent 530 
studies, phacoemulsification in centres familiar with the technique has a similar or lower (62) 531 
PPRD incidence than ECCE. Our survey found an initially high PPRD rate which drops to about 532 
0.1-0.2% per year for several years, still approximately ten times greater than the RRD risk of 533 
the general population.  534 
 535 
Several patient, eye and operative factors are associated with increased PPRD risk, namely (in 536 
order of decreasing effect) intraoperative vitreous loss, increasing axial length, younger age, 537 
male sex and trainee operating surgeon. These are all the known risk factors for PPRD known 538 
from older cataract extraction methods such as ECCE, with the exception of Nd:YAG laser 539 
capsulotomy which appears not to pose a significant PPRD risk in the phacoemulsification 540 
setting and trainee operating surgeon grade which does not seem to have been investigated in 541 
the ECCE setting. Increasing age is protective, with an approximate halving of PPRD risk for 542 
each decade above 50 years. Intraoperative complications and PCR with vitreous loss in 543 
particular increase the PPRD risk more markedly in the initial postoperative phase and form the 544 
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single biggest risk factor for PPRD. These risks are likely to be multiplicative to existing risks 545 
meaning that for example in a young myopic male with a previous fellow eye RRD the risk in the 546 
operative eye can be higher than perhaps previously expected. 547 
 548 
Long term complications of phacoemulsification such as PPRD can easily escape the notice of 549 
cataract surgeons due to increasing sub-specialisation (63). As such, closer monitoring for RRD 550 
postoperatively with prophylactic measures e.g. retinal tear photocoagulation may have a role in 551 
identifying and preventing RRD (64).  552 
 553 
While we are getting a clearer picture of PPRD incidence, the exact risk of PPRD attributable to 554 
phacoemulsification remains elusive. For more effective counselling of patients who might be at 555 
higher risk, ideally a PPRD risk calculator is needed, based on data which accounts for the 556 
limitations of the currently available literature as outlined above. 557 
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Titles and legends to figures 728 
Table 1: Summary of studies meeting review criteria 729 
Figure 1: Cumulative PPRD incidence as reported by the 16 studies included in this review 730 
Table 2: Reproduced from Lin et al. 2013 731 
1 2 3 4 5 6 7 8 9
Lead Author Boberg-Ans Sheu Boberg-Ans Russell Sheu Sheu Szijártó Sheu Olsen
Publication year 2003 2005 2006 2006 2006 2007 2007 2010 2012
Location Denmark Taiwan Denmark New Zealand Taiwan Taiwan Hungary Taiwan Denmark
Method as 
described by 
authors
Retrospective 
review Prospective cohort
Retrospective 
register based 
consecutive 
uncontrolled study
Retrospective 
review Prospective cohort
Prospective cohort 
study
Retrospective 
series
Prospective cohort 
study
Retrospective 
cohort study
Size 6,521 PP eyes 9,398 PP eyes 6,352 PP eyes 1,793 PP eyes 9,398 PP eyes 9,398 PP eyes 11,098 PP eyes 9,388 PP eyes 12,222 PP eyes
Population age 
range/criteria Feb-98 21-99 Feb-98 40-100 21-99 18-99 13-105 18-99 20-101
Study duration 1996-1998 1999-2001 1996-1998 1992-1993 1999-2001 1999-2001 1994-2004 1999-2001 2000-2005
Tumours excuded? No No No No No No No No No
Trauma excluded? No Yes No Yes Yes Yes No Yes No
CLE excluded? Yes (inferred) Yes (inferred) Yes Yes (inferred) Yes (inferred) Yes (inferred) Yes (inferred) Yes (inferred) Yes (inferred)
ECCE excluded? No (<1%) No (37.8%) Yes Yes No (37.8%) No (37.8%) Yes No (37.8%) Yes
Min. potential FU 15 months 1 yr 5 yrs 10 yrs 2 yrs 4 yrs 6 wks 6 yrs 2 yrs
Total PPRDs 22 (unquantified) 44 21 (unquantified) (unquantified) 40 (unquantified) 48
Inferred annual 
PPRD incidence 0.09% 0.13% 0.12% 0.12% 0.19% 0.19% 0.04% 0.29% 0.10%
Time from phaco to 
RD surgery
Highest in 1st yr 
post op
Highest in 1st 2 yrs, 
stable after 3
No sig. period of 
higher risk. 
Remains sig. above 
general population 
6 yrs post op
No sig. period of 
higher risk, median 
39 months - -
Highest in first 
year. Shorter if 
vitreous loss (not if 
just PCR) longer if 
younger - 31 
months vs 10 
months
No sig. period of 
higher risk overall. 
Males with mod. 
and high myopia 
(AL >23 mm) have 
sig. late increase (4 
yrs) in PPRD risk -
ECCE vs Phaco
(all PPRDs post 
phaco) not sig. EXCLUDED EXCLUDED not sig. not sig. EXCLUDED
Higher risk for 
Phaco vs ECCE (8 yr 
PPRD rate 2.91 vs 
1.66%, RR 1.78) 
only sig in 1st yr of 
phaco introduction EXCLUDED
Intraoperative 
complications vs 
not not sig.
no sig. increase 
except if PCR in >60 
yrs -
Higher risk for ant. 
vitrectomy and for 
all complications 
combined, not sig. 
for PCR alone not sig. not sig.
Higher risk for all 
complications 
combined (RR 
20.03. 
Complications were 
zonulolysis and PCR 
with and without 
vitreous loss) not sig.
Higher risk for PCR 
with vitreous loss 
(PCR in 10.4% of 
PPRD pts vs 1.9% of 
general post-phaco 
population)
Surgeon grade - - - - - - - - -
Nd:YAG 
capsulotomy vs not not sig.
No sig. increased 
risk except in age 
<50 yrs - not sig. - not sig. - not sig. not sig.
0.76% cumulative 4 
yr PPRD rateOverall PPRD rate
0.41% 4.33 yr 
cumulative PPRD 
risk
0.4% 3 yr 
cumulative PPRD 
risk
0.93% 8 yr 
cumulative PPRD 
incidence vs. 
1.17% cumulative 
10yr PPRD rate
1.16 cumulative 6 
yr PPRD rate
0.36% cumulative 
10 yr PPRD rate
2.31% cumulative 8 
yr PPRD rate
0.39% cumulative 4 
yr PPRD rate
Myopic vs 
Nonmyopic
Higher risk for 
myopes (AL >25 
mm, risk 
unquantified)
Dose-dependent 
higher risk for 
myopes (3 yr PPRD 
rate 0.25% 0.41% 
and 1.63% for AL 
<23, 23-26 and >26 
mm) Effect not 
significant in >60 yr 
olds -
4.87x higher risk 
for myopes (AL >24 
mm)
Dose-dependent 
higher risk for 
myopes (4 yr PPRD 
rate 0.36%, 0.66% 
and 2.00% for AL 
<23, 23-26 and >26 
mm)
Dose-dependent 
higher risk for 
myopes (RR vs AL 
<23 mm 2.38 and 
6.12 for AL 23-26 
and >26 mm)
Higher risk for 
myopes (RR 6.5 for 
AL >25 vs AL <25 
mm)
Dose-dependent 
higher risk for 
myopes (crude RR 
vs AL <23 mm 1.78 
and 4.61 for AL 23-
26 and >26 mm)
Dose-dependent 
higher risk for 
myopes (4 yr PPRD 
rate 0.18% for AL 
<24 mm vs 2.8% for 
AL 27-28 mm)
Previous RD vs not EXCLUDED EXCLUDED - not sig. EXCLUDED EXCLUDED EXCLUDED EXCLUDED -
Hx of fellow eye RD 
vs none - - -
Minimally sig. 
higher risk - - -
Higher risk (crude 
RR 17.34) -
Ocular trauma Hx 
vs none not sig. EXCLUDED - EXCLUDED EXCLUDED EXCLUDED - EXCLUDED not sig.
Male vs Female
Higher risk for men 
(unquantified) not sig.
Higher risk for men 
(RR 2.5)
Higher risk for men 
(10 yr PPRD rate 
2.1% vs 0.62%) not sig.
Higher risk for men 
(RR 2.42) not sig.
Higher risk for men 
(ARR 1.72)
Higher risk for men 
(58.3% males in 
PPRD population vs 
34.9% in general 
post-phaco 
population)
Age
Higher risk for pts 
aged <65 yrs 
(unquantified)
Dose-dependent 
higher risk in 
younger pts (3 yr 
PPRD rate 1.01%, 
0.67% and 0.29% 
for ages <50, 50-60 
and >60 yrs)
Dose-dependent 
higher risk in 
younger pts (RR vs 
>80 years 10.2, 8.9 
and 2.6 for ages 
<60, 60-69 and 70-
79 yrs)
Higher risk for 
younger pts (10 yr 
PPRD rate 5.17% 
for <50 yrs vs 
0.64% for >70 yrs)
Dose-dependent 
higher risk for 
younger pts (4 yr 
PPRD rate 1.41%, 
0.72% and 0.50% 
for ages <50, 50-60 
and >60 yrs)
Higher risk for 
younger (RR 3.00 
for age <50 vs >60 
yrs)
Higher risk for 
younger pts (RR 
4.75 for age <65 vs 
>65 yrs)
Higher risk for 
younger pts (crude 
RR 2.69 for age <50 
vs >60 yrs)
Higher risk for 
younger pts (mean 
age 60.5 yrs for 
PPRD pts vs 73.7 
yrs for general post-
phaco population)
Systemic disease vs 
not - - - -
not sig. for DM and 
hypertension
not sig. for DM and 
hypertension -
not sig. for DM and 
hypertension -
Ethnicity - - - - - - - - -
Notes
NB. Retrospective 
risk factor analysis. 
Found PPRD risk in 
absence of 
preoperative risk 
factors similar to 
high estimate of 
general population 
RD incidence 
(0.12% 4 yr by 
Norregaard 1996).
Retrospective risk 
factor analysis for 
age, sex, myopia 
and operative 
complications. Also 
prospectively 
calculated PPRD 
incidence with 
varying axial length
10 11 12 13 14 15 16
Quek Bjerrum Lin Daien Day Day et al Petousis
2012 2013 2013 2015 2015 2016 2016
Singapore Denmark Taiwan France UK UK UK
Retrospective case-
control study
Retrospective 
register based 
cohort study
Retrospective 
review Population study
Prospective 
database study
Retrospective Case 
series
Single centre 
database study
24,846 PP eyes 202,226 PP eyes 9,184 PP eyes 2,680,167 PP eyes 180,114 PP eyes 61,907 PP eyes 18,065 PP eyes
(not specified) 40-104 18-96 40+ 18+ 18-104 (not specified)
2001-2003 2000-2010 2000-2010 2009-2012 2006-2010 2006 2005-2014
No Yes No No No No No
No Yes Yes No No No Yes
Yes (inferred) Yes Yes (inferred) Yes Yes (inferred) Yes Yes
No (18.5% ECCE or 
ICCE) Yes No (16.6%) No (<1%) Yes (inferred) Yes Yes
6 months 6 months None (inferred)
None (included 
cataract ops till 
end) 1 year 3 months 3 months (inferred)
39 465 (unquantified) 11,424 108 131 36
1.36 per 1000 
person-years PPRD 
incidence rate (vs 
0.32
fellow eye baseline)
0.05% 0.14% 0.12% 0.25% 0.12% 0.05% 0.04%
-
Highest 6 months 
post op (HR 9 vs 
fellow eye), levels 
off after 2 yrs and 
persists above 
fellow eye 10 yrs 
later (HR 3 vs 
fellow eye) -
Linear increase in 
cumulative risk -
Median 6.3 months 
if uncomplicated, 
44 days if PCR -
- EXCLUDED not sig.
Higher risk for ECCE 
(HR 3.11) EXCLUDED EXCLUDED EXCLUDED
Higher risk for PCR 
(PCR in 23.1% of 
PPRD pts vs 1.0% of 
general post-phaco 
population) EXCLUDED
Higher risk for all 
complications 
combined (ARR 
6.09. Complications 
were PCR with and 
without vitreous 
loss. Complications 
not sig in non-
myopes, AL <23 
mm)
Higher risk for PCR 
with vitrectomy 
(HR 4.36)
Higher risk with 
PCR, decreases 
with time after 
phaco (OR 41.66, 
23.98 and 18.28 at 
3, 6 and 12 
months)
Higher risk for PCR 
(4 yr PPRD rate 
16.47% if PCR vs 
1.83% without)
Higher risk for PCR 
only if with vitreous 
loss (HR 12.83)
- - - -
(Lower 
intraoperative 
complication rate 
with consultants vs 
juniors)
Shorter time to 
PPRD with more 
junior operators 
independent of 
PCR -
- -
No sig. increased 
risk except in high 
myopes (AL >26 
mm) - - - -
0.99% 4 yr 
cumulative PPRD 
rate
0.03% cumulative 3 
month PPRD risk
0.21% cumulative 4 
yr (inferred) 
cumulative PPRD 
0.30% 7 yr 
cumulative PPRD 
rate
0.16% cumulative 
3.5 yr (inferred) 
PPRD rate
0.84% cumulative 7 
yr PPRD rate
- -
Dose-dependent 
higher risk for 
myopes (ARR vs AL 
<23 mm 3.92 and 
18.90 for AL 23-26 
mm and >26 mm)
Higher risk for high 
myopes (HR 6.12 
for AL >26mm) - -
Higher risk for high 
myopes (HR vs AL 
23-25 mm 3.98 for 
AL >25 mm) No sig. 
decreased risk for 
AL <23 mm
- EXCLUDED EXCLUDED EXCLUDED - - -
- - - - - - -
- - EXCLUDED
Higher risk with 
trauma Hx (HR 
3.98) - - -
Higher risk for men 
(76.9% males in 
PPRD population vs 
54% in general post-
phaco population)
Higher risk for men 
(HR 1.74) but 
phaco-attributable 
risk (relative to 
fellow eye) not sig. 
changed by sex not sig.
Higher risk for men 
(HR 2.39) - -
Higher risk for men 
(HR 2.00)
Dose-dependent 
higher risk for 
younger pts (HR vs 
age >70 yrs 20.0 for 
age 31-40 and 3.5 
for age 61-70 yrs)
Dose-dependent 
higher risk for 
younger pts (HR 
14.8 for age 50-60 
yrs vs >80 yrs) but 
phaco-attributable 
risk (relative to 
fellow eye) not sig. 
changed by age 
(except 40-49yr 
women who have 
sig. higher 
attributable risk vs 
70-79 yr old 
women)
Dose-dependent 
higher risk for 
younger pts (ARR vs 
age >60 yrs 20.59 
and 5.78 for <50 
yrs and 50-60 yrs)
Dose-dependent 
higher risk for 
younger pts (HR vs 
age >75 yrs 5.22, 
3.69 and 1.98 for 
age 40-54, 55-64 
and 65-74 yrs) - -
Dose-dependent 
higher risk for 
younger pts (HR vs 
60-80 yrs 5.12 and 
0.16 for <60 and 
>80 yrs)
- -
not sig. for DM and 
hypertension
Higher risk if 
diabetic (HR 1.18%) - - -
not sig. - - - - - -
Young and male 
cataract pts have a 
higher native risk of 
RD. Over 10 yrs the
Hierarchy of risk 
factors for PPRD: 
high myopia, young
additional risk of 
PPRD attributable 
to the phaco per se 
was increased by a 
factor of 4.2 
irrespective of sex 
and age.
age, ECCE, PCR, eye 
trauma, male sex 
and diabetes. Note 
overall PPRD 
incidence 
calculated over 
whole duration of 
study even for 
phacos performed 
partway through.
Note PPRD 
incidence 
calculated over 
whole duration of 
study even for 
phacos performed 
partway through
Retrospective risk 
factor analysis for 
age, sex, myopia 
and operative 
complications. 
Note PPRD 
incidence 
calculated over 
whole duration of 
study even for 
phacos performed 
partway through
Note PPRD 
incidence 
calculated over 
whole duration of 
study even for 
phacos performed 
partway through
Variables AL<23 mm (N=3240) 23mm≤AL<26 mm (N=5518)
Adjusted Relative Risk (95%CI) P Value Adjusted Relative Risk (95%CI)
Age
>60 1 1.75(0.1816.81)
50<age≤60 0.04(07.182E+11) 0.84 13.78(1.25151.99)
≤50 0.05(04.359E+27) 0.93 36.67(3.30407.92)
Capsulotomy
No 1 2.81(0.3324.30)
Yes 0.03(054286105) 0.76 3.94(0.3544.55)
Sex
Female 1 0.02(0136817.09)
Male 0.01(0658818.80) 0.59 3.56(0.3932.31)
Intraoperative complications
No 1 3.44(0.4128.89)
Yes 0.04(09.947E+18) 0.9 14.57(0.91232.92)
CI = confidence interval, AL = axial length
* : P-Value was considered to be significant
AL≥26mm (N=426)
P  Value Adjusted Relative Risk (95%CI) P Value
0.63 10.99(0.69175.75) 0.09
0.03* 34.51(3.09385.58) 0.004*
0.003* 151.80(15.631474.46) <0.001*
0.35 7.25(0.5792.44) 0.13
0.27 43.50(3.56532.22) 0.003*
0.61 9.61(0.74124.63) 0.08
0.26 8.57(0.8784.78) 0.07
0.26 19.08(1.89192.28) 0.01*
0.05* 46.73(1.711278.01) 0.02*
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